Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan in hypertensive children and adolescents
NCT02242344Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 2006
- Primary completion
- Sep 2007
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of telmisartan in hypertension (HTN), sponsored by Boehringer Ingelheim. Started Apr 2006; status: completed.
02
Drugs
telmisartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02242344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02242344.